Nomogram predicts survival in esophageal squamous cell cancer

A nomogram incorporating radiomics and dosiomics features, along with clinical factors, was developed to predict overall survival in esophageal squamous cell carcinoma (ESCC) patients undergoing definitive chemoradiotherapy. Dosiomics features outperformed radiomics features in predicting survival outcomes. The combined model exhibited significant differences in overall survival between high- and low-risk groups, highlighting its potential for personalized treatment strategies in ESCC patients.